Goldman Sachs’s Zai Lab ZLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ZLAB
RI
TCM
RCM
ACM
WP
FLSM
Goldman Sachs's ZLAB Position: Q2 2026 in Review
Goldman Sachs increased its Zai Lab (ZLAB) stake by 1,994% in Q2 2026, buying an estimated $43.6M and bringing the position to 2,315,480 shares worth $44M. The position accounts for ﹤0.01% of the portfolio, ranked #1923.
Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 33 quarters since. The position peaked at $87.8M in Q3 2020. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.
- Goldman Sachs held 2,315,480 shares of Zai Lab worth $44M as of Q2 2026.
- Goldman Sachs bought 2,204,893 Zai Lab shares in Q2 2026, an estimated $43.6M.
- Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1923 holding.
- Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 33 quarters since.
- Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
- 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.